NCT01830686

Brief Summary

The purpose of this study is to help understand the benefits of eating food supplemented with fiber in the form of sugarcane bagasse (the leftover fiber after cane juice is extracted) on glucose metabolism and body weight.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

April 10, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 12, 2013

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
Last Updated

February 3, 2016

Status Verified

February 1, 2016

Enrollment Period

9 months

First QC Date

April 10, 2013

Last Update Submit

February 1, 2016

Conditions

Keywords

Sugarcane bagasse, glucose tolerance, insulin resistance

Outcome Measures

Primary Outcomes (1)

  • The benefit of sugarcane bagasse on glucose tolerance and insulin resistance in adults with established insulin resistance

    Participants will be randomly selected to eat food supplemented with either 1) sugarcane bagasse, 2) another type of fiber of equal weight, or 3) minimal fiber. At baseline each eligible subject will have a 3 hour oral glucose tolerance test. Subjects will consume one brownie and two cookies a day for four weeks. At the end of four weeks, the blood tests conducted at baseline will be repeated.

    4 weeks

Secondary Outcomes (1)

  • The effect of sugarcane bagasse on body weight/composition

    4 weeks

Other Outcomes (1)

  • The effect of sugarcane bagasse on incretin profiles as a mechanism to explain its metabolic effects

    4 Weeks

Study Arms (3)

Sugarcane bagasse

EXPERIMENTAL

10 subjects will consume food (brownies and cookies) made with 13 g of sugarcane bagasse everyday for 4 weeks

Other: Sugarcane bagasse

Non-caloric, non-fermentable fiber

ACTIVE COMPARATOR

10 subjects will consume food (brownies and cookies) made with 13 g of non caloric, non-fermentable fiber everyday for 4 weeks

Other: Non-caloric, non-fermentable fiber

Minimal fiber

PLACEBO COMPARATOR

10 subjects will consume food (brownies and cookies) made with 4 g of dietary fiber everyday for 4 weeks

Other: Minimal fiber

Interventions

One brownie containing 10 g of sugarcane bagasse and 2 cookies containing 3 g of sugarcane bagasse (total of 13 g of sugarcane bagasse per day)

Sugarcane bagasse

One brownie containing 10 g of fiber and 2 cookies containing 3 g of fiber (total of 13 g of non-caloric, non-fermentable fiber per day)

Non-caloric, non-fermentable fiber

One brownie containing 3g of fiber and two cookies containing 1g of fiber (total of 4 g of dietary fiber per day)

Minimal fiber

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Males and females age 18-50 years
  • Body Mass Index ≥ 30 kg/m2 (a ratio of weight to height)
  • Fasting insulin level \>5 µIU/mL, as determined by tests performed during screening

You may not qualify if:

  • Women who are pregnant
  • Past medical history of diabetes
  • History of intestinal surgery such as removal of bowel
  • History of problems with absorbing food such as celiac disease, inflammatory bowel disease, malabsorption syndrome
  • Taking chronic medications for any medical conditions such as diabetes, hypertension, cholesterol, thyroid hormone, etc.
  • Any food allergies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pennington Biomedical Research Center

Baton Rouge, Louisiana, 70808, United States

Location

MeSH Terms

Conditions

Insulin Resistance

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Daniel Hsia, MD

    Pennington Biomedical Research Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 10, 2013

First Posted

April 12, 2013

Study Start

April 1, 2013

Primary Completion

January 1, 2014

Study Completion

December 1, 2014

Last Updated

February 3, 2016

Record last verified: 2016-02

Data Sharing

IPD Sharing
Will not share

Locations